Eric Topol/LinkedIn
May 31, 2026, 15:41
Eric Topol: Replication of Plasma p-tau217 Blood Test for Predicting Alzheimer’s Disease
Eric Topol, Founder and Director of Scripps Research Translational Institute, shared a post on X about a recent article by Xiaqing Jiang et al., published in The Lancet, adding:
”The p-tau217 breakthrough blood test replicated again, predicting Alzheimer’s disease in a large cohort mean age 61.
The cover of the new issue is telling.”
Title: Alzheimer’s disease neuropathology plasma biomarkers and cognition in midlife: a community-based cohort study
Authors: Xiaqing Jiang, Tina D Hoang, Prof Leslie M Shaw, Prof David R Jacobs, Ilya M Nasrallah, Prof R Nick Bryan, Prof Kristine Yaffe
Other posts featuring Eric Topol on Hemostasis Today.
-
May 31, 2026, 15:42Antonio Greco: Balancing Bleeding and Thrombotic Risk After PCI
-
May 31, 2026, 15:32ASH Invites Dynamic Members to Apply for 2027 Leadership and Committee Roles
-
May 31, 2026, 14:39Monique Gore-Massy: Redefining Lupus Innovation Through Patient Partnership
-
May 31, 2026, 14:31Mirjam Teboe: The Golden Rule Behind Reliable Lupus Anticoagulant Testing
-
May 31, 2026, 14:20Improving Access to Care for People Living with Haemophilia and Haemoglobinopathies – NNHF
-
May 31, 2026, 14:07Khadija Mohamed: Beyond Localized Fat – The Hidden Risks of Mesotherapy in Undiagnosed Lipedema
-
May 31, 2026, 13:16Caroline Kisia: Project ECHO Transforms Healthcare Around The World
-
May 31, 2026, 13:11Wolfgang Miesbach: From CD20 to CD38 – A New Dimension in ITTP Therapy
-
May 31, 2026, 13:05Ellia Tootoonchian: Advancing Equitable Care Through Global Collaboration at WFH 2026